-
1
-
-
0027184119
-
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin- secreting β-cells
-
Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B: Exendin-4 is a high potency agonist and truncated exendin (9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting b-cells. J Biol Chem 1993;268:19650-19655. (Pubitemid 23270754)
-
(1993)
Journal of Biological Chemistry
, vol.268
, Issue.26
, pp. 19650-19655
-
-
Goke, R.1
Fehmann, H.-C.2
Linn, T.3
Schmidt, H.4
Krause, M.5
Eng, J.6
Goke, B.7
-
2
-
-
0032932825
-
Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations
-
DOI 10.1007/s001250051111
-
Greig NH, Holloway HW, De Ore KA, Jani D, Wang Y, Zhou J, Garant MJ, Egan JM: Once daily injections of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations. Diabetologia 1999; 42:45-50. (Pubitemid 29039736)
-
(1999)
Diabetologia
, vol.42
, Issue.1
, pp. 45-50
-
-
Greig, N.H.1
Holloway, H.W.2
De Ore, K.A.3
Jani, D.4
Wang, Y.5
Zhou, J.6
Garant, M.J.7
Egan, J.M.8
-
3
-
-
41149091612
-
Glycemic variability
-
Monnier L, Colette C: Glycemic variability. Diabetes Care 2008;31(Suppl 2):S150-S154.
-
(2008)
Diabetes Care
, vol.31
, Issue.SUPPL. 2
-
-
Monnier, L.1
Colette, C.2
-
4
-
-
0031032280
-
Self-monitoring of blood glucose in type I diabetic patients: Comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions
-
Bolinder J, Hagstrom-Toft E, Ungerstedt U, Arner P: Selfmonitoring of blood glucose in type I diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 1997;20:64-70. (Pubitemid 27020043)
-
(1997)
Diabetes Care
, vol.20
, Issue.1
, pp. 64-70
-
-
Bolinder, J.1
Hagstrom-Toft, E.2
Ungerstedt, U.3
Arner, P.4
-
5
-
-
0036481429
-
Continuous subcutaneous glucose monitoring in diabetic patients: A multicenter analysis
-
DOI 10.2337/diacare.25.2.347
-
Maran A, Crepaldi MC, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M: Continuous subcutaneous glucose monitoring in diabetic patients. Diabetes Care 2002;25:347-352. (Pubitemid 41079634)
-
(2002)
Diabetes Care
, vol.25
, Issue.2
, pp. 347-352
-
-
Maran, A.1
Crepaldi, C.2
Tiengo, A.3
Grassi, G.4
Vitali, E.5
Pagano, G.6
Bistoni, S.7
Calabrese, G.8
Santeusanio, F.9
Leonetti, F.10
Ribaudo, M.11
Mario, U.D.I.12
Annuzzi, G.13
Genovese, S.14
Riccardi, G.15
Previti, M.16
Cucinotta, D.17
Giorgino, F.18
Bellomo, A.19
Giorgino, R.20
Poscia, A.21
Varalli, M.22
more..
-
6
-
-
0014848738
-
Mean amplitude of glycemic excursion: A measure of diabetic instability
-
Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursion: a measure of diabetic instability. Diabetes 1970;19: 644-655.
-
(1970)
Diabetes
, vol.19
, pp. 644-655
-
-
Service, F.J.1
Molnar, G.D.2
Rosevear, J.W.3
Ackerman, E.4
Gatewood, L.C.5
Taylor, W.F.6
-
7
-
-
67649199832
-
Diurnal glucose patterns of exenatide once weekly: A 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis
-
Mazze R, Strock E, Morgan B, Wesley D, Bergenstal R, Cuddihy R: Diurnal glucose patterns of exenatide once weekly: a 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis. Endocr Pract 2009; 15:326-334.
-
(2009)
Endocr Pract
, vol.15
, pp. 326-334
-
-
Mazze, R.1
Strock, E.2
Morgan, B.3
Wesley, D.4
Bergenstal, R.5
Cuddihy, R.6
-
8
-
-
67649845862
-
Reduced daily risk of glycemic variability: Comparison of exenatide with insulin glargine
-
McCall AL, Cox DJ, Brodows R, Crean J, Johns D, Kovatchev B: Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargine. Diabetes Technol Ther 2009; 11:339-344.
-
(2009)
Diabetes Technol Ther
, vol.11
, pp. 339-344
-
-
McCall, A.L.1
Cox, D.J.2
Brodows, R.3
Crean, J.4
Johns, D.5
Kovatchev, B.6
-
9
-
-
31144461926
-
Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: Mathematical methods and clinical application
-
DOI 10.1089/dia.2005.7.849
-
Kovatchev BP, Clarke WL, Breton M, Brayman K, McCall A: Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther 2005;7:849-862. (Pubitemid 43133992)
-
(2005)
Diabetes Technology and Therapeutics
, vol.7
, Issue.6
, pp. 849-862
-
-
Kovatchev, B.P.1
Clarke, W.L.2
Breton, M.3
Brayman, K.4
McCall, A.5
-
10
-
-
0034803753
-
The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes
-
Haffner S: The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes. Int J Clin Pract 2001;123(Suppl):24-26.
-
(2001)
Int J Clin Pract
, vol.123
, Issue.SUPPL.
, pp. 24-26
-
-
Haffner, S.1
-
11
-
-
0036021736
-
Postprandial hyperglycemia: Noxious effects on the vessel wall
-
Hanefeld M: Postprandial hyperglycemia: noxious effects on the vessel wall. Int J Clin Pract 2002;129(Suppl):45-50.
-
(2002)
Int J Clin Pract
, vol.129
, Issue.SUPPL.
, pp. 45-50
-
-
Hanefeld, M.1
|